Cryopreservation is a long-term commitment, potentially spanning centuries. For that reason, Tomorrow.bio’s operational and legal structure has been designed with one clear goal: to last.
To ensure that every patient remains safely preserved for as long as necessary, Tomorrow.bio operates as part of a larger ecosystem composed of three distinct organizations, each with a defined role in the continuum of care.
‍
1. The three-pillar system
Tomorrow.bio (Germany)
Tomorrow.bio is the operational and medical branch of the ecosystem. It manages all practical aspects of standby, stabilization, and cryopreservation, from dispatching trained standby teams to performing the surgical procedure and initiating long-term cooldown.
Core responsibilities include:
- Maintaining and training 24/7 standby and surgical teams.
- Executing the full cryopreservation procedure once legal death is declared.
- Handling contracts, member coordination, and communication.
- Providing educational outreach, research collaboration, and public-facing communication about biostasis and cryonics.
Tomorrow.bio operates as a German corporation (GmbH). Its focus is growth, operational excellence, and the continuous improvement of preservation quality through research and technology.
Tomorrow Patient Care Foundation (TPCF – Switzerland)
The Tomorrow Patient Care Foundation safeguards every patient’s long-term interests.
Once a member’s death occurs, the patient’s prearranged payment method (such as life insurance) is triggered, and funds are transferred to the TPCF. This foundation acts as the legal guardian of both the patient’s body and financial capital.
TPCF’s primary functions:
- Receiving and managing funds dedicated to the patient’s preservation.
- Paying Tomorrow.bio for the cryopreservation procedure.
- Managing patient accounts and ensuring adequate resources for indefinite care.
- Monitoring the ongoing preservation activity at the long-term storage facility.
TPCF is a private benefit organization, optimized for stability and oversight. It is legally obligated to protect patient assets and ensure that funds are used solely for the purpose of cryopreservation and maintenance.
European Biostasis Foundation (EBF – Switzerland)
The European Biostasis Foundation (EBF) owns and operates the long-term storage facility in Switzerland.
It is a non-profit foundation dedicated to advancing biostasis research and providing secure, indefinite preservation for patients entrusted to its care.
Core responsibilities:
- Maintaining and improving the cryogenic storage infrastructure.
- Conducting biostasis-related scientific research.
- Providing secure, redundant, and stable long-term storage.
- Issuing annual invoices to the TPCF for patient maintenance costs.
EBF’s facility, located in Switzerland, was chosen for its political neutrality, low natural disaster risk, and strict foundation governance laws that prevent changes of purpose or hostile takeovers.
Patients are preserved underground, in a reinforced concrete facility built to ensure stability under all foreseeable conditions.
‍
2. How the Ecosystem Works Together
The relationship between the three organizations is designed for both efficiency and security.
Below is an overview of the process once a member’s death occurs:
- Member death occurs: The patient’s life insurance or funding mechanism is activated.
- Payment and contract execution: Funds are transferred to the Tomorrow Patient Care Foundation (TPCF).
- Standby team dispatch: Proof of payment triggers Tomorrow.bio’s standby team to begin the cryopreservation procedure.
- Cryopreservation: Tomorrow.bio performs stabilization, perfusion, vitrification, and cooldown to cryogenic temperature.
- Billing: Tomorrow.bio issues a one-time invoice for the performed cryopreservation.
- Payment: The TPCF pays Tomorrow.bio using the funds allocated by the patient’s insurance or prepayment plan.
- Transfer to long-term storage: The patient is placed in the European Biostasis Foundation (EBF) facility for indefinite maintenance.
- Ongoing maintenance: EBF invoices the TPCF annually for upkeep, ensuring stable funding and preservation continuity.
This process ensures that each organization operates independently, reducing conflict of interest while maintaining perfect procedural flow.
‍
3. Why This Structure Exists
Growth and stability
Tomorrow.bio focuses on technological and organizational growth: improving procedures, logistics, and medical readiness.
TPCF and EBF focus on stability: secure long-term financial and physical care of patients.
By separating these functions, Tomorrow.bio can innovate and expand without ever compromising the safety of patients already preserved.
Financial security
Funds are held by the Tomorrow Patient Care Foundation, not by Tomorrow.bio.
This guarantees that even if the operational company changes, patient funds remain protected and fully dedicated to long-term preservation.
The TPCF then pays the European Biostasis Foundation annually to maintain each patient’s storage conditions indefinitely.
This separation ensures transparency, accountability, and continuity even across generations.
‍Legal durability
Both TPCF and EBF are registered in Switzerland, where foundation law provides some of the world’s strictest safeguards.
Once created, a Swiss foundation’s mission cannot be changed or repurposed, making it virtually immune to acquisition, external control, or financial mismanagement.
Combined with Switzerland’s political stability and low natural disaster risk, this legal framework provides a uniquely reliable environment for long-term biostasis care.
‍
4. Built to last
The Tomorrow.bio ecosystem was designed with one guiding principle: indefinite continuity.
Each organization has a distinct and independent role, ensuring that if one changes or evolves, the others can continue their responsibilities without interruption.
- Tomorrow.bio ensures operational excellence and continuous improvement.
- TPCF safeguards patient rights and financial integrity.
- EBF guarantees physical protection, research, and long-term storage stability.
